Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process-Reference-Cited by-同舟云学术

Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process

Published:2023-08-31 Issue:3 Volume:21 Page:447-456
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Kim Hye Ri¹^ORCID,Kim Sun Mi¹^ORCID,Kang Won Sub²^ORCID,Jeon Hong Jun³^ORCID,Jang Seung-Ho⁴^ORCID,Jon Duk-In⁵^ORCID,Hong Jeongwan⁶^ORCID,Jeong Jong-Hyun⁷^ORCID

Affiliation:

1. Department of Psychiatry, Chung-Ang University College of Medicine, Seoul, Korea

2. Department of Psychiatry, College of Medicine, Kyung Hee University, Seoul, Korea

3. Department of Psychiatry, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea

4. Department of Psychiatry, Wonkwang University School of Medicine, Iksan, Korea

5. Department of Psychiatry, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea

6. Department of Psychiatry, Iksan Hospital, Iksan, Korea

7. Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea

Funder

Korean Psychosomatic Society

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Link

http://pdf.medrang.co.kr/CPN2/2023/021/cpn021-03-05.pdf

Reference36 articles.

1. Psychotropic-Induced Hyperprolactinemia: A Clinical Review

2. Clinical guidelines for diagnosis and treatment of prolactinoma and hyperprolactinemia

3. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone11This work was sponsored by Eli Lilly and Company.

4. Antipsychotic-Induced Hyperprolactinaemia

5. The Prevalence of Hyperprolactinemia After Long-term Haloperidol Use in Patients With Chronic Schizophrenia